序号 | 股票代码 | 股票简称 | 纳入时间 | 申万1级 | 申万2级 | 申万3级 | 价格
|
市盈率
|
市盈率ttm
|
市净率
|
股息率
|
市值(亿元)
|
归母净利润同比增长(12-31)
|
归母净利润同比增长(09-30)
|
营业收入同比增长(12-31)
|
营业收入同比增长(09-30)
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 603456.SH | 九洲药业 | 2023-07-06 | — | — | 医疗研发外包 | 13.87 | 20.49 | 20.04 | 1.41 | 3.59% | 124.17 | -41.34% | -34.74% | -6.57% | -13.36% |
2 | 300363.SZ | 博腾股份 | 2014-02-12 | — | — | 医疗研发外包 | 14.67 | — | — | 1.53 | 3.3% | 80.02 | -207.83% | -145.68% | -17.87% | -30.02% |
3 | 301520.SZ | 万邦医药 | 2023-10-10 | — | — | 医疗研发外包 | 36.51 | 28.46 | 35.96 | 1.63 | 2.33% | 24.34 | -20.87% | 0.63% | 10.91% | 21.88% |
4 | 600721.SH | 百花医药 | 2008-01-25 | — | — | 医疗研发外包 | 6.83 | 63.25 | 63.25 | 3.46 | — | 26.24 | 219.75% | 35.39% | 4.46% | 9.38% |
5 | 300149.SZ | 睿智医药 | 2010-12-29 | — | — | 医疗研发外包 | 5.75 | — | — | 2.14 | — | 28.63 | — | -96.88% | — | -15.09% |
6 | 688238.SH | 和元生物 | 2023-09-25 | — | — | 医疗研发外包 | 5.48 | — | — | 2.19 | — | 35.57 | -151.54% | -166.90% | 21.16% | 34.22% |
7 | 301096.SZ | 百诚医药 | 2021-12-27 | — | — | 医疗研发外包 | 33.0 | — | — | 1.41 | 0.9% | 36.05 | -119.39% | -29.69% | -21.18% | 1.07% |
8 | 301201.SZ | 诚达药业 | 2022-01-27 | — | — | 医疗研发外包 | 20.45 | — | — | 1.48 | 0.96% | 31.64 | -130.89% | -33.98% | -19.59% | -6.34% |
9 | 301333.SZ | 诺思格 | 2022-08-09 | — | — | 医疗研发外包 | 44.26 | 30.49 | 30.49 | 2.33 | 0.45% | 42.75 | -13.73% | -32.93% | 3.14% | 7.10% |
10 | 301509.SZ | 金凯生科 | 2023-08-10 | — | — | 医疗研发外包 | 30.66 | 95.65 | 53.3 | 1.68 | 1.86% | 36.93 | -77.76% | -73.13% | -35.19% | -33.93% |
11 | 300347.SZ | 泰格医药 | 2012-08-24 | — | — | 医疗研发外包 | 45.05 | 96.18 | 96.18 | 1.89 | 1.25% | 389.66 | -79.99% | -56.72% | -10.58% | -10.32% |
12 | 688710.SH | 益诺思 | 2024-09-10 | — | — | 医疗研发外包 | 32.63 | 23.66 | 31.13 | 1.92 | — | 46.00 | — | -26.47% | — | 10.46% |
13 | 688202.SH | 美迪西 | 2023-09-25 | — | — | 医疗研发外包 | 28.63 | — | — | 1.8 | — | 38.56 | -896.21% | -211.99% | -24.01% | -32.24% |
14 | 688265.SH | 南模生物 | 2023-09-25 | — | — | 医疗研发外包 | 24.97 | — | 296.71 | 1.16 | — | 19.47 | — | -3.99% | — | -1.17% |
15 | 002821.SZ | 凯莱英 | 2016-11-25 | — | — | 医疗研发外包 | 74.47 | 28.3 | 27.03 | 1.56 | 2.39% | 268.54 | -58.17% | -67.86% | -25.82% | -35.14% |
16 | 688131.SH | 皓元医药 | 2023-09-25 | — | — | 医疗研发外包 | 37.59 | 39.34 | 39.34 | 2.87 | — | 79.30 | 58.17% | 21.31% | 20.75% | 17.65% |
17 | 300759.SZ | 康龙化成 | 2019-02-11 | — | — | 医疗研发外包 | 23.19 | 22.99 | 22.99 | 3.03 | 0.86% | 412.36 | 12.01% | 24.82% | 6.39% | 3.00% |
18 | 688046.SH | 药康生物 | 2023-09-25 | — | — | 医疗研发外包 | 11.31 | 29.18 | 40.05 | 2.17 | — | 46.37 | -30.89% | -16.57% | 10.39% | 12.13% |
19 | 300404.SZ | 博济医药 | 2015-05-04 | — | — | 医疗研发外包 | 9.1 | 143.22 | 78.17 | 3.52 | 0.11% | 34.86 | 18.23% | 87.98% | 33.50% | 55.01% |
20 | 300683.SZ | 海特生物 | 2024-07-31 | — | — | 医疗研发外包 | 22.2 | — | — | 1.22 | 0.59% | 29.06 | 42.60% | -50.32% | 7.75% | 2.87% |
21 | 688621.SH | 阳光诺和 | 2023-09-25 | — | — | 医疗研发外包 | — | — | — | — | — | — | -3.98% | 21.40% | 15.70% | 32.47% |
22 | 300725.SZ | 药石科技 | 2017-11-17 | — | — | 医疗研发外包 | 31.85 | 28.98 | 30.9 | 2.2 | 0.97% | 63.61 | 11.24% | -14.45% | -2.12% | -12.67% |
23 | 301257.SZ | 普蕊斯 | 2022-05-24 | — | — | 医疗研发外包 | 28.28 | 16.69 | 21.19 | 1.99 | 0.98% | 22.48 | — | -28.39% | — | 9.17% |
24 | 688073.SH | 毕得医药 | 2023-09-25 | — | — | 医疗研发外包 | 41.49 | 32.11 | 30.9 | 1.85 | — | 37.71 | 7.17% | -26.05% | 0.93% | 0.79% |
25 | 301230.SZ | 泓博医药 | 2022-11-08 | — | — | 医疗研发外包 | 28.25 | 230.83 | 230.83 | 3.82 | 1.24% | 39.43 | -54.59% | -66.81% | 11.18% | 6.59% |
26 | 603127.SH | 昭衍新药 | 2017-09-01 | — | — | 医疗研发外包 | 15.54 | 157.23 | 157.23 | 1.44 | 1.03% | 116.47 | -81.34% | -121.46% | -15.07% | -15.87% |
27 | 603259.SH | 药明康德 | 2018-05-15 | — | — | 医疗研发外包 | 57.36 | 17.53 | 17.53 | 2.83 | 1.74% | 1656.55 | -1.63% | -19.11% | -2.73% | -6.23% |
28 | 688222.SH | 成都先导 | 2023-09-25 | — | — | 医疗研发外包 | 14.16 | 139.34 | 111.39 | 4.07 | — | 56.74 | 26.13% | 64.71% | 14.99% | 21.38% |
免责声明:数据相关栏目所收集数据,均来自第三方个人或企业公开数据以及国家统计网站公开发布数据,数据由计算机技术自动收集更新再由作者校验,作者将尽力校验,但不能保证数据的完全准确。 阅读本栏目的用户必须明白,图表所示结果或标示仅供学习参考使用,均不构成交易依据。任何据此进行交易等行为,而引致的任何损害后果,本站概不负责。